End of 2018 - beginning of 2019
launching of the Newway 2021 plan
Spineway designs, produces and markets innovative implant lines and ancillary surgical equipment which are used to treat severe spinal column pathologies.
launching of the Newway 2021 plan
market development in the USA.
Launch of the Mont Blanc MIS. Establishment of Spineway USA Inc in Florida and 1er strategic partner in the US with a first order of 2m$.
Update of the Mont Blanc and Blue Mountain approvals in USA.
Launch of the TLIF cage and the Mont Blanc 3D+ instrumentation at the Eurospine 2014 congress.
Launch on the Paris Alternext/NYSE Stock Exchange.
Final development of Mont Blanc 3D+, a real innovation in operating techniques for the treatment of idiopathic scoliosis. 9 patents – 48 distributors
Innovation with Kili, an anterior thoraco-lumbar cage, which facilitates the implantation procedure and improves post-operational life quality. 8 patents – 40 distributors
Development of Mont Blanc Baby, a line specifically adapted to pediatric needs (starting at ten months). 6 patents – 28 distributors
Introduction of the flagship Mont Blanc line with a rear fixation system which is able to cover 60% of pathologies. 3 patents – 17 distributors
Creation of the Spineway Company by two spinal implant professionals: Stéphane Le Roux and Philippe Laurito. First sales – 7 distributors
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.